Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell

Cardiovascular Research

Volumn 92, Issue 1, 2011, Pages 115-122

  David, Robert ^a   Jarsch, Veronica Barbara ^a   Schwarz, Florian ^a   Nathan, Petra ^a   Gegg, Moritz ^b   Lickert, Heiko ^b   Franz, Wolfgang Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Brachyury(T); Cardiovasculogenesis; Embryogenesis; MesP1; Pluripotent stem cells

Indexed keywords

EOMESODERMIN; MESSENGER RNA; MYOCYTE ENHANCER FACTOR 2; SHORT HAIRPIN RNA; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRACHYURY; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR MESODERM POSTERIOR1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; HEART MUSCLE CELL; IN SITU HYBRIDIZATION; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARDIOVASCULAR SYSTEM; CELLS, CULTURED; EMBRYONIC STEM CELLS; FETAL PROTEINS; HUMANS; MICE; MULTIPOTENT STEM CELLS; MYOCYTES, CARDIAC; T-BOX DOMAIN PROTEINS;

EID: 80052880254     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr158     Document Type: Article

References (41)

1. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005;6:826-835.
2. Kitajima S, Takagi A, Inoue T, Saga Y. MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development 2000;127:3215-3226. (Pubitemid 30649534)
3. Saga Y, Kitajima S, Miyagawa-Tomita S. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med 2000;10:345-352. (Pubitemid 32448044)
4. Saga Y, Miyagawa-Tomita S, Takagi A, Kitajima S, Miyazaki J, Inoue T. MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development 1999;126:3437-3447. (Pubitemid 29396783)
5. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49. (Pubitemid 46865811)
6. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-386.
7. David R, Brenner C, Stieber J, Schwarz F, Brunner S, Vollmer M et al. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol 2008;10:338-345. (Pubitemid 351331021)
8. Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, Mashayekhi M et al. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell 2008;3:55-68.
9. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 2008;3:69-84.
10. David R, Stieber J, Fischer E, Brunner S, Brenner C, Pfeiler S et al. Forward programming of pluripotent stem cells towards distinct cardiovascular cell types. Cardiovasc Res 2009;84:263-272.
11. Sakurai H, Era T, Jakt LM, Okada M, Nakai S, Nishikawa S. In vitro modeling of paraxial and lateral mesoderm differentiation reveals early reversibility. Stem Cells 2006;24: 575-586. (Pubitemid 44464761)
12. Bondue A, Blanpain C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 2010;107:1414-1427.
13. Izumi N, Era T, Akimaru H, Yasunaga M, Nishikawa S. Dissecting the molecular hierarchy for mesendoderm differentiation through a combination of embryonic stem cell culture and RNA interference. Stem Cells 2007;25:1664-1674. (Pubitemid 47121843)
14. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006;11:723-732. (Pubitemid 44644969)
15. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. Faseb J 2000;14: 2540-2548.
16. Kanno S, Kim PK, Sallam K, Lei J, Billiar TR, Shears LL II. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci USA 2004;101: 12277-12281. (Pubitemid 39145434)
17. Lickert H, Kutsch S, Kanzler B, Tamai Y, Taketo MM, Kemler R. Formation of multiple hearts in mice following deletion of beta-catenin in the embryonic endoderm. Dev Cell 2002;3:171-181.
18. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, Keller G et al. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 2003;130:4217-4227. (Pubitemid 37063436)
19. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91: 501-508.
20. Xu XQ, Graichen R, Soo SY, Balakrishnan T, Rahmat SN, Sieh S et al. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 2008;76:958-970.
21. Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji G et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997;29: 1525-1539. (Pubitemid 27270224)
22. Takahashi T, Lord B, Schulze PC, Fryer RM, Sarang SS, Gullans SR et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 2003;107:1912-1916. (Pubitemid 36444134)
23. Ventura C, Maioli M, Asara Y, Santoni D, Mesirca P, Remondini D et al. Turning on stem cell cardiogenesis with extremely low frequency magnetic fields. Faseb J 2005; 19:155-157. (Pubitemid 40069950)
24. Gassanov N, Er F, Zagidullin N, Hoppe UC. Endothelin induces differentiation of ANP-EGFP expressing embryonic stem cells towards a pacemaker phenotype. Faseb J 2004;18:1710-1712. (Pubitemid 39561659)
25. Mummery CL, Ward D, Passier R. Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium. Curr Protoc Stem Cell Biol 2007;Chapter 1, Unit 1F.2.
26. Graichen R, Xu X, Braam SR, Balakrishnan T, Norfiza S, Sieh S et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 2008;76:357-370. (Pubitemid 351522761)
27. Srivastava D, Ivey KN. Potential of stem-cell-based therapies for heart disease. Nature 2006;441:1097-1099. (Pubitemid 43990723)
28. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee JH et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006;440:1199-1203.
29. Shao H, Wei Z, Wang L, Wen L, Duan B, Mang L et al. Generation and characterization of mouse parthenogenetic embryonic stem cells containing genomes from nongrowing and fully grown oocytes. Cell Biol Int 2007;31:1336-1344. (Pubitemid 47361870)
30. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008;14:14.
31. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007;25:1177-1181. (Pubitemid 47538112)
32. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26:101-106.
33. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131: 861-872. (Pubitemid 350138099)
34. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
35. Teramura T, Onodera Y, Murakami H, Ito S, Mihara T, Takehara T et al. Mouse androgenetic embryonic stem cells differentiated to multiple cell lineages in three embryonic germ layers in vitro. J Reprod Dev 2009;55:283-292.
36. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI et al. Perfusiondecellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-221. (Pubitemid 351214548)
37. David R, Groebner M, Franz WM. Magnetic cell sorting purification of differentiated embryonic stem cells stably expressing truncated human CD4 as surface marker. Stem Cells 2005;23:477-482. (Pubitemid 40478486)
38. Maltsev VA, Rohwedel J, Hescheler J, Wobus AM. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 1993;44:41-50. (Pubitemid 24037697)
39. Maltsev VA,Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 1994;75:233-244. (Pubitemid 24228315)
40. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-458.
41. Eschenhagen T, Zimmermann WH, Kleber AG. Electrical coupling of cardiac myocyte cell sheets to the heart. Circ Res 2006;98:573-575.